The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans

Pharmaceutical Biology

Volumn 54, Issue 6, 2016, Pages 984-992

  Shao, Jing ^a   Zhang, Mengxiang ^a   Wang, Tianming ^a   Li, Yue ^a   Wang, Changzhong ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Efflux pump; fluconazole resistance; gene expression; rhodamine 6G; synergism

Indexed keywords

ABC TRANSPORTER; FLUCONAZOLE; KAEMPFEROL; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN CDR1; PROTEIN CDR2; UNCLASSIFIED DRUG; CARRIER PROTEIN; CDR1 PROTEIN, CANDIDA ALBICANS; FUNGAL PROTEIN; KAEMPFEROL DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL STRAIN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG POTENTIATION; GENE EXPRESSION; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST;

CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION; KAEMPFEROLS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; P-GLYCOPROTEIN;

EID: 84945237269     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2015.1091483     Document Type: Article

References (36)

1. Abdelmegeed E, Shaaban MI. 2013. Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans. J Microbiol. 51:598-604.
2. Cannon RD, Lamping E, Holmes AR, Baret PV, Keniya MV, Tanabe K, Niimi M, Goffeau A, Monk BC. 2009. Effluxmediated antifungal drug resistance. Clin Microbiol Rev. 22:291-321.
3. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts-third edition: approved standard M27-A3. Wayne, PA: CLSI.
4. da Silva CR, de Andrade Neto JB, de Sousa Campos R, Figueiredo NS, Sampaio LS, Magalhaes HI, Cavalcanti BC, Gaspar DM, de Andrade GM, Lima IS. 2014. Synergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole. Antimicrob Agents Chemother. 58:1468-1478.
5. Eliopoulos G, Eliopoulos C. 1988. Antibiotic combinations: should they be tested? Clin Microbiol Rev. 1:139-156.
6. Friedman M. 2007. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol Nutr Food Res. 51:116-134.
7. Hirasawa M, Takada K. 2004. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. J Antimicrob Chemother. 53:225-229.
8. Holler JG, Christensen SB, Slotved HC, Rasmussen HB, Gúzman A, Olsen CE, Petersen B, Molgaard P. 2012. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees. J Antimicrob Chemother. 67:1138-1144.
9. Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD. 2012. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates. Antimicrob Agents Chemother. 56:1508-1515.
10. Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC, Cannon RD. 2008. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother. 52:3851-3862.
11. Huang S, Cao YY, Dai BD, Sun XR, Zhu ZY, Cao YB, Wang Y, Gao PH, Jiang YY. 2008. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole. Biol Pharm Bull. 31:2234-2236.
12. Kataoka M, Hirata K, Kunikata T, Hirata K, Kunikata T, Ushio S, Iwaki K, Ohashi K, Ikeda M, Kurimoto M. 2001. Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils. J Gastroenterol. 36:5-9.
13. Khodavandi A, Alizadeh F, Vanda NA, Karimi G, Chong PP. 2014. Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans. Pharm Biol. 52:1505-1509.
14. Khodavandi A, Harmal NS, Alizadeh F, Harmal NS, Alizadeh F, Scully OJ, Sidik SM, Othman F, Sekawi Z, Ng KP, Chong PP. 2011. Comparison between allicin and fluconazole in Candida albicans biofilm inhibition and in suppression of HWP1 gene expression. Phytomedicine 19:56-63.
15. Kohli A, Gupta V, Krishnamurthy S, Hasnain SE, Prasad R. 2001. Specificity of drug transport mediated by CaMDR1: A major facilitator of Candida albicans. J Biosci. 26:333-339.
16. Lamping E, Monk BC, Niimi K, Holmes AR, Tsao S, Tanabe K, Niimi M, Uehara Y, Cannon RD. 2007. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryotic Cell. 6:1150-1165.
17. Letscher-Bru V, Obszynski C, Samsoen M, Sabou M, Waller J, Candolfi E. 2013. Antifungal activity of sodium bicarbonate against fungal agents causing superficial infections. Mycopathologia 175:153-158.
18. Martino R, Canale F, Sülsen V, Alonso R, Davicino R, Mattar A, Anesini C, Micalizzi B. 2014. A fraction containing kaempferol-3,4'-dimethylether from Larrea divaricata Cav. induces macrophage activation on mice infected with Candida albicans. Phytother Res. 28:917-924.
19. Nakamura K, Niimi M, Niimi K, Holmes AR, Yates JE, Decottignies A, Monk BC, Goffeau A, Cannon RD. 2001. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob Agents Chemother. 45:3366-3374.
20. Niimi M, Niimi K, Takano Y, Holmes AR, Fischer FJ, Uehara Y, Cannon RD. 2004. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. J Antimicrob Chemother. 54:999-1006.
21. Odds F. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 52:1.
22. Orhan DD, Ozcelik B, Ozgen S, Ergun F. 2010. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol Res. 165:496-504.
23. Peralta MA, Calise M, Fornari MC, Ortega MG, Diez RA, Cabrera JL, Perez C. 2012. A prenylated flavanone from Dalea elegans inhibits rhodamine 6 G efflux and reverses fluconazole-resistance in Candida albicans. Planta Med. 78:981-987.
24. Pinho E, Ferreira IC, Barros L, Carvalho AM, Soares G, Henriques M. 2014. Antibacterial potential of northeastern Portugal wild plant extracts and respective phenolic compounds. BioMed Res Int. 2014:1-8.
25. Prasad R, Rawal MK. 2014. Efflux pump proteins in antifungal resistance. Front Pharmacol. 5:1-13.
26. Rajasekharan SK, Ramesh S, Bakkiyaraj D. 2014. Synergy of flavonoids with HDAC inhibitor: new approach to target Candida tropicalis biofilms. J Chemother. [Epub ahead of print]. doi:10.1179/1973947814Y.0000000186.
27. Rajendran P, Rengarajan T, Nandakumar N, Palaniswami R, Nishigaki Y, Nishigaki I. 2014. Kaempferol, a potential cytostatic and cure for inflammatory disorders. Eur J Med Chem. 86:103-112.
28. Schulz B, Weber K, Schmidt A, Borg-von Zepelin M, Ruhnke M. 2011. Difference in virulence between fluconazolesusceptible and fluconazole-resistant Candida albicans in a mouse model. Mycoses 54:e522-e530.
29. Shao J, Wang T, Yan Y, Shi G, Cheng H, Wu D, Wang C. 2014. Matrine reduces yeast-to-hypha transition and resistance of a fluconazole-resistant strain of Candida albicans. J Appl Microbiol. 117:618-626.
30. Staniszewska M, Bondaryk M, Swoboda-Kopec E, Siennicka K, Sygitowicz G, Kurzatkowski W. 2013. Candida albicans morphologies revealed by scanning electron microscopy analysis. Braz J Microbiol. 44:813-821.
31. Tatsimo SJ, Tamokou JD, Havyarimana L, Csupor D, Forgo P, Hohmann J, Kuiate JR, Tane P. 2012. Antimicrobial and antioxidant activity of kaempferol rhamnoside derivatives from Bryophyllum pinnatum. BMC Res Notes. 5:158.
32. Tobudic S, Kratzer C, Lassnigg A, Presterl E. 2012. Antifungal susceptibility of Candida albicans in biofilms. Mycoses 55:199-204.
33. Tsang PW, Chau KY, Yang HP. 2015. Baicalein exhibits inhibitory effect on the energy-dependent efflux pump activity in non-albicans Candida fungi. J Chemother. 27:61-62.
34. Xu D, Jiang B, Ketela TLemieux S, Veillette K, Martel N, Davison J, Sillaots S, Trosok S, Bachewich C, 2007. Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathog. 3:e92.
35. Zhang X, Guo H, Gao LSong Y, Li S, Zhang H, 2013. Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans. Pharm Biol. 51:749-752.
36. Zhou Y, Wang G, Li Y, Liu Y, Song Y, Zheng W, Zhang N, Hu X, Yan S, Jia J. 2012. In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis. Antimicrob Agents Chemother. 56:3250-3260.